
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 233
Feargal J. Ryan, Christopher M. Hope, Makutiro G. Masavuli, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 233
Showing 1-25 of 233 citing articles:
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
Daniel Ayoubkhani, Charlotte Bermingham, Koen B. Pouwels, et al.
BMJ (2022), pp. e069676-e069676
Open Access | Times Cited: 355
Daniel Ayoubkhani, Charlotte Bermingham, Koen B. Pouwels, et al.
BMJ (2022), pp. e069676-e069676
Open Access | Times Cited: 355
Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases
Andreas Zollner, Robert Koch, A Jukic, et al.
Gastroenterology (2022) Vol. 163, Iss. 2, pp. 495-506.e8
Open Access | Times Cited: 244
Andreas Zollner, Robert Koch, A Jukic, et al.
Gastroenterology (2022) Vol. 163, Iss. 2, pp. 495-506.e8
Open Access | Times Cited: 244
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 173
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 173
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
Chris Greene, Ruairi Connolly, Declan Brennan, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 3, pp. 421-432
Open Access | Times Cited: 168
Chris Greene, Ruairi Connolly, Declan Brennan, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 3, pp. 421-432
Open Access | Times Cited: 168
Long COVID: pathophysiological factors and abnormalities of coagulation
Simone Turner, Asad Khan, David Putrino, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 6, pp. 321-344
Open Access | Times Cited: 145
Simone Turner, Asad Khan, David Putrino, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 6, pp. 321-344
Open Access | Times Cited: 145
Viral persistence, reactivation, and mechanisms of long COVID
Benjamin K. Chen, Boris Jülg, Sindhu Mohandas, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 144
Benjamin K. Chen, Boris Jülg, Sindhu Mohandas, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 144
Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics
Albert Leng, Manuj Shah, Syed A. Ahmad, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 816-816
Open Access | Times Cited: 119
Albert Leng, Manuj Shah, Syed A. Ahmad, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 816-816
Open Access | Times Cited: 119
Why has the epidemiology of RSV changed during the COVID-19 pandemic?
Bahaa Abu-Raya, Marina Viñeta Paramo, Frederic Reicherz, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102089-102089
Open Access | Times Cited: 109
Bahaa Abu-Raya, Marina Viñeta Paramo, Frederic Reicherz, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102089-102089
Open Access | Times Cited: 109
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
Milena Wiech, Piotr Chrościcki, Julian Swatler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84
Milena Wiech, Piotr Chrościcki, Julian Swatler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 84
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Long COVID and rehabilitation
Hung‐Jui Chuang, Chia-Wei Lin, Ming‐Yen Hsiao, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, pp. S61-S69
Open Access | Times Cited: 57
Hung‐Jui Chuang, Chia-Wei Lin, Ming‐Yen Hsiao, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, pp. S61-S69
Open Access | Times Cited: 57
The plasma metabolome of long COVID patients two years after infection
Yamilé López‐Hernández, Joel Monárrez‐Espino, David Alejandro García López, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Yamilé López‐Hernández, Joel Monárrez‐Espino, David Alejandro García López, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Thromboinflammation in long COVID—the elusive key to postinfection sequelae?
Leo Nicolai, Rainer Kaiser, Konstantin Stark
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 8, pp. 2020-2031
Open Access | Times Cited: 51
Leo Nicolai, Rainer Kaiser, Konstantin Stark
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 8, pp. 2020-2031
Open Access | Times Cited: 51
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 44
Manish Dhawan, Ali A. Rabaan, Sara Alwarthan, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 699-699
Open Access | Times Cited: 44
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 36
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 36
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
Aimee L. Hanson, Matthew P. Mulè, Hélène Ruffieux, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 471-482
Open Access | Times Cited: 22
Aimee L. Hanson, Matthew P. Mulè, Hélène Ruffieux, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 471-482
Open Access | Times Cited: 22
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 20
Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease
Ludmila Müller, Svetlana Di Benedetto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 753-753
Open Access | Times Cited: 19
Ludmila Müller, Svetlana Di Benedetto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 753-753
Open Access | Times Cited: 19
Deciphering sepsis: transforming diagnosis and treatment through systems immunology
Robert E. W. Hancock, Andy An, Claúdia C. dos Santos, et al.
Frontiers in Science (2025) Vol. 2
Open Access | Times Cited: 2
Robert E. W. Hancock, Andy An, Claúdia C. dos Santos, et al.
Frontiers in Science (2025) Vol. 2
Open Access | Times Cited: 2
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
Clara Di Vito, Francesca Calcaterra, Nicolò Coianiz, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 46
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 46
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
Javier García-Abellán, Marta Fernández‐González, Sergio Padilla, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Javier García-Abellán, Marta Fernández‐González, Sergio Padilla, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Doan C. Nguyen, Pedro A. Lamothe, Matthew C. Woodruff, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 40-63
Open Access | Times Cited: 41
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 41
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 41